CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Clinical trials for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA explained in plain language.
Never miss a new study
Get alerted when new CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA trials appear
Sign up with your email to follow new studies for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy trial aims to tame deadly heart rhythms
Disease control Recruiting nowThis early-stage trial tests a single dose of SGT-501, a gene therapy given by IV, in 18 people with a rare inherited heart condition called CPVT that can cause dangerous fast heartbeats during exercise or stress. The main goal is to check safety and find the right dose in adults…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE1 • Sponsor: Solid Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to tame rare, Exercise-Triggered heart condition
Disease control Recruiting nowThis study tests an experimental drug called CRD-4730 in 12 adults with a rare inherited heart condition (CPVT) that can cause dangerous heart rhythms during exercise or stress. Participants will receive two different doses of the drug and a placebo in random order to see if it s…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New pill could tame deadly heart flutters during exercise
Disease control Recruiting nowThis study tests a new oral drug called AGP100 in people with a rare inherited heart condition (CPVT) that can cause dangerously fast heartbeats during stress or exercise. Ten adults aged 18-75 will take three different doses of AGP100 over six weeks while continuing their usual …
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE2 • Sponsor: Agiana Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New heart test could predict sudden cardiac death risk
Diagnosis Recruiting nowThis study aims to develop a new clinical test to diagnose Calcium Release Deficiency Syndrome (CRDS), a rare inherited heart condition that increases the risk of sudden cardiac arrest. Researchers will use a pacing procedure to measure heart wave changes in 400 participants, inc…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: NA • Sponsor: Population Health Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Simple cheek swab could predict sudden cardiac death risk
Diagnosis Recruiting nowThis study explores whether a quick, painless cheek swab can spot protein changes linked to inherited heart conditions that cause sudden cardiac death in young people. Researchers will collect samples from 26 patients with arrhythmic disorders or family members at risk. If the te…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Sponsor: St. George's Hospital, London • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Brazil launches massive heart gene hunt to unlock hereditary mysteries
Knowledge-focused Recruiting nowThis study is building a registry of 1,211 people in Brazil who have inherited heart conditions like cardiomyopathy, arrhythmias, and Marfan syndrome. Researchers will collect DNA samples and medical information to discover which genes are most commonly affected and how often the…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Sponsor: Hospital do Coracao • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC